Exploring the Pattern of Metabolic Alterations Causing Energy Imbalance via PPARα Dysregulation in Cardiac Muscle During Doxorubicin Treatment
- 14 February 2022
- journal article
- research article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 22 (5) , 436-461
Abstract
Cardiotoxicity by anthracycline antineoplastic drug doxorubicin is one of the systemic toxicity of the cardiovascular system. The mechanism responsible for doxorubicin cardiotoxicity and lipid metabolism remains elusive. The current study tested the hypotheses that the role of peroxisome proliferator-activated receptor α (PPARα) in the progress of doxorubicin-induced cardiomyopathy and its mechanism behind lipid metabolism. In the present study, male rats were subjected to intraperitoneal injection (5-week period) of doxorubicin with different dosages such as low dosage (1.5 mg/kg body weight) and high dosage (15 mg/kg body weight) to induce doxorubicin cardiomyopathy. Myocardial PPARα was impaired in both low dosage and high dosage of doxorubicin-treated rats in a dose-dependent manner. The attenuated level of PPARα impairs the expression of the genes involved in mitochondrial transporter, fatty acid transportation, lipolysis, lipid metabolism, and fatty acid oxidation. Moreover, it disturbs the reverse triacylglycerol transporter apolipoprotein B-100 (APOB) in the myocardium. Doxorubicin elevates the circulatory lipid profile and glucose. Further aggravated lipid profile in circulation impedes the metabolism of lipid in cardiac tissue, which causes a lipotoxic condition in the heart and subsequently associated disease for the period of doxorubicin treatment. Elevated lipids in the circulation translocate into the heart dysregulates lipid metabolism in the heart, which causes augmented oxidative stress and necro-apoptosis and mediates lipotoxic conditions. This finding determines the mechanistic role of doxorubicin-disturbed lipid metabolism via PPARα, which leads to cardiac dysfunction.Keywords
Funding Information
- Indian Council of Medical Research (F.No.5/7/482/2010-RBMH&, CH)
- VIT SEED GRANT
This publication has 84 references indexed in Scilit:
- Increased Beta2-Adrenoceptors in Doxorubicin-Induced Cardiomyopathy in RatPLOS ONE, 2013
- Identification of the molecular basis of doxorubicin-induced cardiotoxicityNature Medicine, 2012
- An improved non-enzymatic “DNA ladder assay” for more sensitive and early detection of apoptosisCytotechnology, 2011
- Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonistBritish Journal of Pharmacology, 2011
- Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axisJournal of Molecular and Cellular Cardiology, 2011
- Mouse Cardiac Acyl Coenzyme A Synthetase 1 Deficiency Impairs Fatty Acid Oxidation and Induces Cardiac HypertrophyMolecular and Cellular Biology, 2011
- Targeting NRF2 signaling for cancer chemopreventionToxicology and Applied Pharmacology, 2010
- DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates LipotoxicityJournal of Biological Chemistry, 2009
- The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative DiseaseAntioxidants & Redox Signaling, 2009
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences, 2008